APA

Lim D. M., Gulati R., Aleshin-Guendel S., Gawne A., Wingate J. T., Cheng H. H., Etzioni R. & Yu E. Y. (2018). Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival. : The Prostate.

Chicago

Lim Daniel M, Gulati Roman, Aleshin-Guendel Serge, Gawne Agnes, Wingate Jonathan T, Cheng Heather H, Etzioni Ruth and Yu Evan Y. 2018. Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival. : The Prostate.

Harvard

Lim D. M., Gulati R., Aleshin-Guendel S., Gawne A., Wingate J. T., Cheng H. H., Etzioni R. and Yu E. Y. (2018). Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival. : The Prostate.

MLA

Lim Daniel M, Gulati Roman, Aleshin-Guendel Serge, Gawne Agnes, Wingate Jonathan T, Cheng Heather H, Etzioni Ruth and Yu Evan Y. Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival. : The Prostate. 2018.